v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 9 Months Ended 179 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
OPERATING ACTIVITIES      
Net loss $ (2,272,559) $ (4,681,206) $ (48,133,286)
Depreciation     52,694
Loss on write-off of equipment     36,623
Stock-based compensation including in product development expenses 4,497 1,749 683,541
Stock-based compensation included in interest expenses   2,616,602 13,330,984
Stock-based compensation included in selling, general and administration expenses 63,959 46,591 3,357,104
Stock-based compensation included in professional expenses 111,928 20,989 156,743
Imputed interest expenses 131,987 124,167 3,299,063
Unpaid Interest expense on lines of credit 417,551 286,738 1,039,836
Equity instruments issued to settle liabilities     1,871,718
Advances accrued 30,000   0
Other non-cash items included in net loss     294,020
(Increase) decrease in prepaid expenses 16,253 (32,269) (576)
Increase in accounts payable and accrued liabilities 89,372 49,662 1,595,314
Increase in interest payable 379,304 372,680 4,655,220
Income tax receivable     8,727
Net cash used in operating activities (1,027,708) (1,194,297) (17,752,275)
INVESTING ACTIVITIES      
Purchase of equipment     (43,078)
Net cash used in investing activities     (43,078)
FINANCING ACTIVITIES      
Proceeds from borrowings on line of credit 1,073,638 1,191,069 5,167,604
Proceeds from issuance of promissory notes     9,418,676
Proceeds from issuance of shares     1,512,403
Proceeds from (repayment of) advances payable (20,000) 5,000 3,162,071
Repayment of promissory notes and advances payable     (970,879)
Repurchase of common stock     (342,038)
Other financing activities     (115,472)
Net cash provided by financing activities 1,053,638 1,196,069 17,832,365
Change in cash 25,930 (1,772) 37,012
Cash, beginning of period 11,082 11,002  
Cash, end of period 37,012 12,774 37,012
Shares issued to settle liabilities 30,000   6,837,473
Cash paid for interest     $ 1,223,335